Biotech Investor Relations and Capital Markets Advisory
From biotech. For biotech.™
Welcome to Kendall Investor Relations
Strategic & Operational IR Services
We are former biotech executives with hands-on experience as corporate Investor Relations Officers and extensive R&D and commercial industry know-how. We are deeply integrated in the investment community and understand how biotech investors think.
Fluent in both science and capital markets
Our R&D background enables a genuine understanding of your programs. Our experience across investor relations, corporate development, finance, and commercial operations means we can position that understanding into investor communications that are both credible and compelling.
How We're Different
We've been the client. Our founder led IR at Biogen and Seres Therapeutics.
Ph.D.-level scientific fluency. We engage as peers on your development programs.
Capital markets judgment. Built across over 50 financings and more than $3B raised.
Senior-led engagements. From strategy through execution.
Independent thinking. Grounded in operating experience, unafraid to challenge convention or disagree when it matters.
REPRESENTATIVE CLIENT PARTNERS
